Denali Advisors LLC Fulcrum Therapeutics, Inc. Transaction History

Denali Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$6.7 - $12.0 $205,690 - $368,400	-30,700 Reduced 53.11%	27,100 $255,000
Q4 2023 Jan 19, 2024	SELL	$3.18 - $6.86 $40,704 - $87,808	-12,800 Reduced 18.13%	57,800 $390,000
Q3 2023 Oct 19, 2023	BUY	$3.25 - $6.08 $229,450 - $429,248	70,600 New	70,600 $313,000
Q4 2021 Jan 21, 2022	BUY	$14.0 - $28.44 $54,600 - $110,916	3,900 New	3,900 $69,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $169M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Denali Advisors LLC with notifications on news.